HK Stock MarketDetailed Quotes

02427 GUANZE MEDICAL

Watchlist
  • 0.450
  • +0.030+7.14%
Market Closed Nov 8 16:08 CST
427.50MMarket Cap34.62P/E (TTM)

GUANZE MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
-46.21%40.03M
-11.88%156.07M
-24.55%74.41M
-16.09%177.11M
-7.60%98.62M
14.44%211.08M
10.49%106.73M
30.97%184.44M
--96.59M
7.78%140.83M
Operating income
-46.21%40.03M
-11.88%156.07M
-24.55%74.41M
-16.09%177.11M
-7.60%98.62M
14.44%211.08M
10.49%106.73M
30.97%184.44M
96.59M
7.78%140.83M
Cost of sales
41.80%-18.15M
26.49%-70.67M
47.14%-31.18M
28.99%-96.14M
16.13%-59M
-10.19%-135.38M
-3.35%-70.34M
-30.13%-122.86M
---68.06M
0.96%-94.41M
Operating expenses
41.80%-18.15M
26.49%-70.67M
47.14%-31.18M
28.99%-96.14M
16.13%-59M
-10.19%-135.38M
-3.35%-70.34M
-30.13%-122.86M
-68.06M
0.96%-94.41M
Gross profit
-49.39%21.88M
5.47%85.41M
9.09%43.23M
6.97%80.98M
8.90%39.63M
22.94%75.7M
27.54%36.39M
32.66%61.58M
28.53M
31.35%46.42M
Selling expenses
36.46%-8.45M
-13.16%-26.56M
-8.54%-13.3M
5.89%-23.47M
-5.41%-12.25M
-47.10%-24.94M
-24.49%-11.62M
-42.21%-16.96M
---9.34M
-0.28%-11.92M
Administrative expenses
-4.80%-6.86M
47.87%-14.33M
0.12%-6.54M
-54.05%-27.5M
29.14%-6.55M
-360.26%-17.85M
-501.95%-9.25M
-9.92%-3.88M
---1.54M
12.09%-3.53M
Research and development expenses
-105.45%-1.51M
-181.92%-1.53M
-296.76%-734K
-36.87%-542K
10.19%-185K
66.58%-396K
-68.85%-206K
12.80%-1.19M
---122K
43.45%-1.36M
Impairment and provision
-19.58%-1.64M
-2,039.00%-4.28M
-1,008.06%-1.37M
-373.97%-200K
10.79%-124K
159.84%73K
-172.55%-139K
-17.31%-122K
---51K
-215.15%-104K
-Other impairment is provision
-19.58%-1.64M
-2,039.00%-4.28M
-1,008.06%-1.37M
-373.97%-200K
10.79%-124K
159.84%73K
-172.55%-139K
-17.31%-122K
---51K
-215.15%-104K
Special items of operating profit
-118.35%-355K
-53.18%809K
17.99%1.94M
61.50%1.73M
39.81%1.64M
198.05%1.07M
71.74%1.17M
145.89%359K
--683K
135.48%146K
Operating profit
-86.80%3.07M
27.48%39.51M
4.79%23.21M
-7.91%30.99M
35.52%22.15M
-15.43%33.65M
-10.03%16.35M
34.22%39.79M
18.17M
73.77%29.65M
Financing cost
34.49%-264K
16.49%-861K
38.75%-403K
-72.70%-1.03M
-110.22%-658K
24.33%-597K
-5.74%-313K
-1,447.06%-789K
---296K
-628.57%-51K
Earning before tax
-87.72%2.8M
29.00%38.65M
6.12%22.81M
-9.36%29.96M
34.06%21.49M
-15.24%33.06M
-10.29%16.03M
31.79%39M
17.87M
73.55%29.6M
Tax
56.04%-2.94M
8.12%-10.73M
-9.70%-6.68M
-16.89%-11.68M
-25.20%-6.09M
-0.29%-9.99M
-7.89%-4.87M
-36.98%-9.96M
---4.51M
-61.43%-7.27M
After-tax profit from continuing operations
-100.85%-137K
52.70%27.92M
4.70%16.13M
-20.73%18.29M
37.92%15.4M
-20.57%23.07M
-16.43%11.17M
30.10%29.04M
13.36M
77.89%22.32M
Earning after tax
-100.85%-137K
52.70%27.92M
4.70%16.13M
-20.73%18.29M
37.92%15.4M
-20.57%23.07M
-16.43%11.17M
30.10%29.04M
13.36M
77.89%22.32M
Minority profit
-87.08%23K
3.80%355K
106.98%178K
157.14%342K
19.44%86K
--133K
--72K
----
----
----
Profit attributable to shareholders
-101.00%-160K
53.63%27.57M
4.13%15.95M
-21.76%17.94M
38.04%15.32M
-21.03%22.94M
-16.97%11.1M
30.10%29.04M
13.36M
77.89%22.32M
Basic earnings per share
-101.18%-0.0002
50.00%0.03
-15.00%0.017
-33.33%0.02
0.02
0.03
Diluted earnings per share
-101.18%-0.0002
-15.00%0.017
0.02
0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover -46.21%40.03M-11.88%156.07M-24.55%74.41M-16.09%177.11M-7.60%98.62M14.44%211.08M10.49%106.73M30.97%184.44M--96.59M7.78%140.83M
Operating income -46.21%40.03M-11.88%156.07M-24.55%74.41M-16.09%177.11M-7.60%98.62M14.44%211.08M10.49%106.73M30.97%184.44M96.59M7.78%140.83M
Cost of sales 41.80%-18.15M26.49%-70.67M47.14%-31.18M28.99%-96.14M16.13%-59M-10.19%-135.38M-3.35%-70.34M-30.13%-122.86M---68.06M0.96%-94.41M
Operating expenses 41.80%-18.15M26.49%-70.67M47.14%-31.18M28.99%-96.14M16.13%-59M-10.19%-135.38M-3.35%-70.34M-30.13%-122.86M-68.06M0.96%-94.41M
Gross profit -49.39%21.88M5.47%85.41M9.09%43.23M6.97%80.98M8.90%39.63M22.94%75.7M27.54%36.39M32.66%61.58M28.53M31.35%46.42M
Selling expenses 36.46%-8.45M-13.16%-26.56M-8.54%-13.3M5.89%-23.47M-5.41%-12.25M-47.10%-24.94M-24.49%-11.62M-42.21%-16.96M---9.34M-0.28%-11.92M
Administrative expenses -4.80%-6.86M47.87%-14.33M0.12%-6.54M-54.05%-27.5M29.14%-6.55M-360.26%-17.85M-501.95%-9.25M-9.92%-3.88M---1.54M12.09%-3.53M
Research and development expenses -105.45%-1.51M-181.92%-1.53M-296.76%-734K-36.87%-542K10.19%-185K66.58%-396K-68.85%-206K12.80%-1.19M---122K43.45%-1.36M
Impairment and provision -19.58%-1.64M-2,039.00%-4.28M-1,008.06%-1.37M-373.97%-200K10.79%-124K159.84%73K-172.55%-139K-17.31%-122K---51K-215.15%-104K
-Other impairment is provision -19.58%-1.64M-2,039.00%-4.28M-1,008.06%-1.37M-373.97%-200K10.79%-124K159.84%73K-172.55%-139K-17.31%-122K---51K-215.15%-104K
Special items of operating profit -118.35%-355K-53.18%809K17.99%1.94M61.50%1.73M39.81%1.64M198.05%1.07M71.74%1.17M145.89%359K--683K135.48%146K
Operating profit -86.80%3.07M27.48%39.51M4.79%23.21M-7.91%30.99M35.52%22.15M-15.43%33.65M-10.03%16.35M34.22%39.79M18.17M73.77%29.65M
Financing cost 34.49%-264K16.49%-861K38.75%-403K-72.70%-1.03M-110.22%-658K24.33%-597K-5.74%-313K-1,447.06%-789K---296K-628.57%-51K
Earning before tax -87.72%2.8M29.00%38.65M6.12%22.81M-9.36%29.96M34.06%21.49M-15.24%33.06M-10.29%16.03M31.79%39M17.87M73.55%29.6M
Tax 56.04%-2.94M8.12%-10.73M-9.70%-6.68M-16.89%-11.68M-25.20%-6.09M-0.29%-9.99M-7.89%-4.87M-36.98%-9.96M---4.51M-61.43%-7.27M
After-tax profit from continuing operations -100.85%-137K52.70%27.92M4.70%16.13M-20.73%18.29M37.92%15.4M-20.57%23.07M-16.43%11.17M30.10%29.04M13.36M77.89%22.32M
Earning after tax -100.85%-137K52.70%27.92M4.70%16.13M-20.73%18.29M37.92%15.4M-20.57%23.07M-16.43%11.17M30.10%29.04M13.36M77.89%22.32M
Minority profit -87.08%23K3.80%355K106.98%178K157.14%342K19.44%86K--133K--72K------------
Profit attributable to shareholders -101.00%-160K53.63%27.57M4.13%15.95M-21.76%17.94M38.04%15.32M-21.03%22.94M-16.97%11.1M30.10%29.04M13.36M77.89%22.32M
Basic earnings per share -101.18%-0.000250.00%0.03-15.00%0.017-33.33%0.020.020.03
Diluted earnings per share -101.18%-0.0002-15.00%0.0170.020.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data